METX.F logo

ME Therapeutics Holdings OTCPK:METX.F Stock Report

Last Price

US$2.95

Market Cap

US$60.4m

7D

0%

1Y

n/a

Updated

09 Oct, 2024

Data

Company Financials

ME Therapeutics Holdings Inc.

OTCPK:METX.F Stock Report

Market Cap: US$60.4m

METX.F Stock Overview

A preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. More details

METX.F fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

ME Therapeutics Holdings Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for ME Therapeutics Holdings
Historical stock prices
Current Share PriceCA$2.95
52 Week HighCA$2.95
52 Week LowCA$2.95
Beta0
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO0%

Recent News & Updates

Recent updates

Shareholder Returns

METX.FUS BiotechsUS Market
7D0%-0.8%-0.2%
1Yn/a6.0%28.8%

Return vs Industry: Insufficient data to determine how METX.F performed against the US Biotechs industry.

Return vs Market: Insufficient data to determine how METX.F performed against the US Market.

Price Volatility

Is METX.F's price volatile compared to industry and market?
METX.F volatility
METX.F Average Weekly Movementn/a
Biotechs Industry Average Movement10.3%
Market Average Movement6.3%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: METX.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine METX.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aSalim Dhanjiwww.metherapeutics.com

ME Therapeutics Holdings Inc., a preclinical stage biotechnology company, engages in the development of cancer fighting drugs in the field of immuno-oncology. Its lead candidate is a novel antibody drug that targets a key protein involved in the generation of suppressive myeloid cells. The company was incorporated in 2021 and is headquartered in Vancouver, Canada.

ME Therapeutics Holdings Inc. Fundamentals Summary

How do ME Therapeutics Holdings's earnings and revenue compare to its market cap?
METX.F fundamental statistics
Market capUS$60.44m
Earnings (TTM)US$0
Revenue (TTM)n/a

n/a

P/E Ratio

n/a

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
METX.F income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$0
EarningsUS$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)0
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0.0%

How did METX.F perform over the long term?

See historical performance and comparison